Results appeared in the Journal of Clinical Oncology. Among girls ages 15 to 17, adjusted efficacy estimates were 35% (95% CI, 19% to 65%) for high-grade squamous intraepithelial lesions, 21%
Regional variations in the cost of care are “rampant,” according to an opinion piece in the June 10 Annals by Eric Horwitz, MD, chair of the department of radiation oncology and
D. Multiple myeloma. The correct answer is D: Multiple myeloma. This question can be found in MKSAP 15 in the Hematology and Oncology section, item 29.
But, don't forget that neuroscience research is relevant to neurosurgery. Any oncology research on head and neck cancer is still relevant for ear nose and throat doctors, and so forth. ... It's also important to remember that as a first year student,
This applies in other fields, including oncology. I get this. It's an under-discussed aspect of being a doctor, articulated well in some characters' pathology and passion. .
The suggestion from the authors, Drs. Smith and Hillner, is that doctors better integrate palliative care into usual oncology care.
Saba, MD, FACP, professor of hematology, medical oncology, and otolaryngology, and director of the head and neck oncology program at Winship Cancer Institute at Emory University in Atlanta.
The correct answer is A: Glucose 6-phosphate dehydrogenase (G6PD) deficiency. This question can be found in MKSAP 15 in the Hematology and Oncology section, item 3.
The correct answer is C: Myelofibrosis. This question can be found in MKSAP 15 in the Hematology and Oncology section, item 27.
CLABSIs. The end result is that hospitals with large populations of oncology patients are forced to report falsely elevated CLABSI rates.